image
Healthcare - Biotechnology - NASDAQ - GB
$ 3.08
2.33 %
$ 896 M
Market Cap
-2.7
P/E
BALANCE SHEET
375 M ASSETS
-23.43%
264 M LIABILITIES
37.74%
111 M EQUITY
-62.68%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Autolus Therapeutics plc
image
Current Assets 275 M
Cash & Short-Term Investments 240 M
Receivables 24.5 M
Other Current Assets 11.2 M
Non-Current Assets 100 M
Long-Term Investments 0
PP&E 95.7 M
Other Non-Current Assets 4.43 M
Current Liabilities 44.7 M
Accounts Payable 103 K
Short-Term Debt 10.1 M
Other Current Liabilities 34.5 M
Non-Current Liabilities 219 M
Long-Term Debt 47.9 M
Other Non-Current Liabilities 171 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Sep-2018 Sep-2017 Sep-2016 Sep-2015
ASSETS
Cash & Cash Equivalents 239.6 382.4 310.3 153.3 210.6 189.3 137.1 28.1 10.2
Short Term Investments 0 0 0 0 0 0 0 0 0
Receivables 24.5 0.2 68 K 29.7 30.5 9.3 4.7 2.2 0
Inventory (23.5) 14.2 10.1 (29.7) 7.8 2.2 0 0 0
Other Current Assets 34.7 43.2 36.5 14.0 8.1 2.9 0.7 0.7 1.3
Total Current Assets 275.3 425.8 347.0 197.0 249.3 199.1 142.5 30.9 11.5
PP&E 95.7 58.4 52.3 89.7 51.6 9.2 6.2 3.3 0.9
Intangible Assets 0 0 65 K 0.2 0.3 9.3 0 9.5 10.2
Goodwill 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0
Other Long Term Assets 1.4 4.0 4.4 5.7 2.0 0 0 (9.5) 0
Other Assets 0 0 0 0 0 1 0 0 0
Total Assets 375.4 490.3 405.6 294.2 303.5 217.7 148.7 34.2 22.7
LIABILITIES
Accounts Payable 0.1 0.5 0.4 2.3 1.1 3.0 1.9 1.4 1.7
Short Term Debt 10.1 10.1 4.5 7.2 5.0 0 0 0 0
Other Current Liabilities 34.5 35.8 23.7 24.2 18.5 13.5 2.9 1.3 0.3
Total Current Liabilities 44.7 46.4 28.6 33.6 25.0 12.5 5.0 2.7 1.9
Long Term Debt 47.9 19.2 16.5 50.6 23.7 0.4 0.3 0.2 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0
Other Liabilities 171.3 126.0 47.1 0 0 0.2 0.8 0.6 0
Total Liabilities 263.9 191.6 92.2 84.2 48.7 12.5 6.1 3.5 1.9
EQUITY
Common Stock 8 K 8 K 4 K 3 K 2 K 1.28 K 1 K 577 322
Retained Earnings (878.6) (670.2) (521.3) (379.2) (237.2) 163.8 (47.9) (28.2) (9.3)
Other Accumulative Comprehensive Income/Loss (29.0) (38.9) (8.6) (5.9) (8.7) (76.3) (3.8) (4.7) 0
Total Equity 111.5 298.7 313.3 210.0 254.8 205.1 142.6 30.7 20.7
Total Liabilities and Equity 375.4 490.3 405.6 294.2 303.5 217.7 148.7 34.2 22.7
SHARES OUTSTANDING
Common Shares Outstanding 173.9 95.0 72.1 51.6 43.1 31.6 13.8 13.8 13.8